Voyager Therapeutics Stock (NASDAQ: VYGR)

Voyager Therapeutics

VOYAGER THERAPEUTICS INC

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Biotech

Earnings

Earnings Beats

News

Penny Stocks

Small Cap

Markets

Trading Ideas

General

ANIP

LGND

PBYI

VYGR

Puma Biotechnology, Inc. (NASDAQ: PBYI) reported first-quarter 2024 adjusted loss of 5 cents per share, which was narrower than the Zacks Consensus Estimate of a loss of 16 cents. In the year-ago quarter, the company had reported adjusted earnings of 9 cents.

Puma Biotechnology&#39;s Q1 Earnings and Revenues Beat

pharma lab worker ai

Analyst Color

Equities

Health Care

Price Target

Initiation

Analyst Ratings

Movers

NBIX

SGMO

Unlock potential with Voyager Therapeutics as HC Wainwright initiates coverage highlights its TRACER capsid platform, promising CNS-targeted gene therapies and strategic partnerships driving long-term value.

Analyst Bullish On Gene Therapy-Focused Voyager Therapeutics Sees Best In Class Potential For Its Neurogenetic Medicine Platform

Wall Street bull

Large Cap

Macro Economic Events

Mid Cap

Broad U.S. Equity ETFs

Currency ETFs

Econ #s

Economics

Federal Reserve

Pre-Market Outlook

Tech

ETFs

AVGO

BBWI

BFLY

DUOL

ENPH

FIGS

IRWD

LPSN

MNST

NFLX

NVDA

PLCE

STER

TSLA

PowerShares DB US Dollar Index Bullish Fund

XMTR

Tech stocks drive pre-market surge, Fed inflation data fails to disrupt rate cut expectations. Futures up for Nasdaq, S&amp;P 500, and small caps.

Tech Stocks Set To Rise Thursday As January Inflation Data Fails To Scare Markets, Small Caps Surge

Voyager Therapeutics, Inc. - Common Stock

Voyager Therapeutics Inc

Press Releases

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Voyager Therapeutics, Inc. - VYGR

Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Legal

Bragar Eagel & Squire, P.C. Is Investigating Dave, Red Cat, Perpetua, and Voyager and Encourages Investors to Contact the Firm

Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025

Voyager Next-Generation CNS Capsids Featured at ASGCT 28th Annual Meeting

Voyager Reports First Quarter 2025 Financial and Operating Results

Voyager Demonstrates ALPL Receptor-Mediated Blood-Brain Barrier Transport of Novel AAV Capsids in Molecular Therapy Publication

DAVE

PPTA

RCAT

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Anika Therapeutics

Perspective Therapeutics, Inc. Common Stock

Perspective Therapeutics

Cardiff Oncology

Cargo Therapeutics

Design Therapeutics

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals

4D Molecular Therapeutics, Inc. - Common Stock

4D Molecular Therapeutics

TuHURA Biosciences

Inhibrx Biosciences

INmune Bio

Innate Pharma S.A. - American Depositary Shares

Innate Pharma

Kodiak Sciences

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals

Nanobiotix

Puma Biotechnology

Quoin Pharmaceuticals, Ltd. - American Depositary Shares

Quoin Pharmaceuticals

AVITA Medical

TransCode Therapeutics, Inc. - Common Stock

TransCode Therapeutics

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Tiziana Life Sciences Ltd - Common Shares

Tiziana Life Sciences

TriSalus Life Sciences, Inc. - Common Stock

TriSalus Life Sciences

Tango Therapeutics

Tonix Pharmaceuticals Holding Corp. - Common Stock

Tonix Pharmaceuticals

Y-mAbs Therapeutics

HC Wainwright & Co.

Canaccord Genuity

Wells Fargo

Citigroup

Leerink Partners

Comments

Voyager Therapeutics

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell